Safety and Tolerability of the Potassium Binder Patiromer From a Global Pharmacovigilance Database Collected Over 4 Years Compared with Data from the Clinical Trial Program

Patrick Rossignol, Lea David, Christine S. Chan, Ansgar Conrad, Matthew R. Weir
ISSN / E-ISSN
— / —
DOI
10.1007/s40801-021-00254-7 ↗
Volume · Issue · Pages
8 · 3 · 315-323
Publisher
Springer International Publishing AG
Article URL
https://doi.org/10.1007/s40801-021-00254-7 ↗
Article details
Unverified
Publication date (each date has its type and source)
20 May 2021
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date20 May 2021 OpenAlex

Keywords (as given): patiromer; potassium binders; hyperkalemia; adverse events; safety and tolerability; pharmacovigilance; clinical trial comparison; mortality; constipation; diarrhea; hypomagnesemia; hypocalcemia; hypokalemia; drug-induced hypomagnesemia; reporting rates

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Journal
Drugs - Real World Outcomes
Publication date used
20 May 2021 (OpenAlex publication date)
Applicable HEC period
None recorded for this date
Category
—
Recognition status
Unknown (NO_PERIOD_FOR_DATE)
Source
—
Verification status
Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.